SPRY ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥11/5/2026
EPSå®çžŸïŒUSDïŒ-0.36
売äžé«å®çžŸïŒUSDïŒ37.71M
ARS Pharmaceuticals Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® ARS Pharmaceuticals Inc ã®æ±ºç®å ±åæžã次å ARS Pharmaceuticals Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãARS Pharmaceuticals Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠ARS Pharmaceuticals Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
SPRY 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
SPRY FY2025 決ç®
EPS (å幎åææ¯)-1.74-2206.28%
売äžé« (å幎åææ¯)84.28M-5.46%
ARS Pharmaceuticals IncïŒSPRYïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | -0.36/-0.32 | 37.71M/41.99M | -12.44% | -10.20% |
| 8/13/2026 | 06/2026 | -0.63/-0.49 | 33.66M/31.32M | -27.45% | 7.46% |
| 5/15/2026 | 03/2026 | -0.61/-0.53 | 22.68M/22.23M | -16.17% | 2.03% |
| 3/9/2026 | 12/2025 | -0.42/-0.44 | 28.09M/25.58M | 5.52% | 9.79% |
| 11/10/2025 | 09/2025 | -0.52/-0.47 | 32.50M/28.95M | -9.68% | 12.26% |
| 8/13/2025 | 06/2025 | -0.46/-0.47 | 15.72M/13.78M | 2.91% | 14.09% |
| 5/14/2025 | 03/2025 | -0.35/-0.35 | 7.97M/7.48M | 0.16% | 6.57% |
| 3/20/2025 | 12/2024 | 0.51/-0.14 | 86.58M/15.82M | 466.20% | 447.36% |
ARS Pharmaceuticals Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ARSãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºïŒSPRYïŒ2026幎第2ååæ決ç®èª¬æäŒïŒneffyã®ã·ã§ã¢æ¡å€§ãšã³ã¹ããªã»ãã
ARSãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºã®2026幎第2ååæ決ç®èª¬æäŒã«ãããŠãneffyã®ã·ã§ã¢æ¡å€§ã«äŒŽã売äžé«ã¯3,370äžãã«ã«éãããäžæ¹ã§çµå¶é£ã¯ã³ã¹ãåæžãå®æœãã2027幎ãŸã§ã®ãã£ãã·ã¥ããŒã¹ã§ã®æçåå²ç¹å°éãç®æããŠããã